Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
Neurology Advisor spoke with Dr Peter McAllister about how to best discern migraine with aura from stroke.
Migraine headache is associated with a higher risk for major adverse cardiovascular and cerebrovascular events.
Consensus statement cautions against the use of hormonal contraceptives in women with migraine, as these medications may be associated with an increased risk for ischemic stroke.
The diagnostic criteria formulated by the ACTTION-APS Pain Taxonomy working group focus on neuropathic pain from SCI, stroke, and MS.
Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.
Dr Pamela Rist discusses her research in women with migraine and hypertension at the 2017 American Academy of Neurology Annual Meeting in Boston, MA. Scroll to below the video for a full text transcript of Dr Rist's interview.
Head Computed Tomography Safe in Pregnant Women Presenting With Headache in the Emergency DepartmentMay 10, 2017
MRI is ordered more often than CT for pregnant patients with headache, despite no significant difference in radiation risk.
The risk for developing hypertension was slightly higher in women with a history of migraine compared with women who do not have a history of the condition.
Patients with a history of migraine have an increased risk for ischemic stroke after surgery, leading to more hospital readmissions.
Stroke preventive measures should be considered in women with a history of migraine headache.
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Predictors of Opioid Overdose in High-Risk Users
- FDA to Review Long-Acting Treatment for Opioid Use Disorder
- Half of Patients Referred for Behavioral Treatment of Migraine Never Initiate Treatment
- Low-Dose Sumatriptan Injection Effective as Acute Migraine Treatment
- The Fight for Patient Privacy Under Big Data Analytics